Bruker Corporation

NasdaqGS:BRKR Voorraadrapport

Marktkapitalisatie: US$9.0b

Bruker Beheer

Beheer criteriumcontroles 4/4

De CEO Bruker is Frank Laukien, benoemd in Feb1991, heeft een ambtstermijn van 33.75 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 5.86M, bestaande uit 15.8% salaris en 84.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 26.59% van de aandelen van het bedrijf, ter waarde $ 2.39B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 10.6 jaar en 9.3 jaar.

Belangrijke informatie

Frank Laukien

Algemeen directeur

US$5.9m

Totale compensatie

Percentage CEO-salaris15.8%
Dienstverband CEO33.8yrs
Eigendom CEO26.6%
Management gemiddelde ambtstermijn10.6yrs
Gemiddelde ambtstermijn bestuur9.3yrs

Recente managementupdates

Recent updates

Bruker: Still Challenged, Certainly Margins

Nov 02

Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

Oct 25
Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Sep 10
We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Bruker: Multiple Risks And Declining Returns On Capital Aren't Priced In

Aug 22

Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 22
Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Jun 09
Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Bruker: A Confusing Acquisition Spree

May 31

Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

May 09
Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

Bruker Corporation: An Aggressive Acquisition Strategy

Apr 24

Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research

Apr 11

Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

Jan 22
Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Jan 08
There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Dec 26
Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Nov 06
Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Is Bruker (NASDAQ:BRKR) Using Too Much Debt?

Oct 23
Is Bruker (NASDAQ:BRKR) Using Too Much Debt?

Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors

Sep 25
Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors

Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

Aug 09
Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 27
Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet

Jul 11
Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet

If EPS Growth Is Important To You, Bruker (NASDAQ:BRKR) Presents An Opportunity

Jun 26
If EPS Growth Is Important To You, Bruker (NASDAQ:BRKR) Presents An Opportunity

Analyse CEO-vergoeding

Hoe is Frank Laukien's beloning veranderd ten opzichte van Bruker's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

US$352m

Mar 31 2024n/an/a

US$402m

Dec 31 2023US$6mUS$926k

US$427m

Sep 30 2023n/an/a

US$319m

Jun 30 2023n/an/a

US$319m

Mar 31 2023n/an/a

US$312m

Dec 31 2022US$5mUS$873k

US$297m

Sep 30 2022n/an/a

US$275m

Jun 30 2022n/an/a

US$274m

Mar 31 2022n/an/a

US$282m

Dec 31 2021US$6mUS$812k

US$277m

Sep 30 2021n/an/a

US$270m

Jun 30 2021n/an/a

US$238m

Mar 31 2021n/an/a

US$204m

Dec 31 2020US$4mUS$689k

US$158m

Sep 30 2020n/an/a

US$158m

Jun 30 2020n/an/a

US$165m

Mar 31 2020n/an/a

US$177m

Dec 31 2019US$5mUS$753k

US$197m

Sep 30 2019n/an/a

US$207m

Jun 30 2019n/an/a

US$189m

Mar 31 2019n/an/a

US$184m

Dec 31 2018US$4mUS$731k

US$180m

Sep 30 2018n/an/a

US$98m

Jun 30 2018n/an/a

US$92m

Mar 31 2018n/an/a

US$84m

Dec 31 2017US$5mUS$704k

US$79m

Compensatie versus markt: De totale vergoeding ($USD 5.86M ) Frank } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 8.06M ).

Compensatie versus inkomsten: De vergoeding van Frank is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Frank Laukien (64 yo)

33.8yrs

Tenure

US$5,858,761

Compensatie

Dr. Frank H. Laukien, Ph D., serves as the Chairman, Chief Executive Officer and President of Bruker Corporation at Bruker BioSpin GmbH since February 1991. Dr. Laukien serves as the Chairman, Chief Execut...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Frank Laukien
Chairman33.8yrsUS$5.86m26.59%
$ 2.4b
Gerald Herman
Executive VP & CFO6.7yrsUS$2.20m0.033%
$ 2.9m
Mark Munch
Corporate Executive VP and President of Bruker Nano Group & Corporate9.3yrsUS$2.73m0.050%
$ 4.5m
Juergen Srega
President of Bruker CALID Group & Bruker Daltonics Division11.8yrsUS$1.47m0.081%
$ 7.3m
Falko Busse
President of Bruker BioSpin Group6.5yrsUS$1.35m0.016%
$ 1.4m
Justin Ward
Senior Director of Investor Relations & Corporate Developmentno datageen gegevensgeen gegevens
J. Alldredge
General Counsel & Secretaryno datageen gegevensgeen gegevens
Burkhard Prause
President and CEO of Bruker Energy & Supercon Technologies16.6yrsUS$967.91k0.0090%
$ 807.0k

10.6yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van BRKR is doorgewinterd en ervaren (gemiddelde ambtstermijn van 10.6 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Frank Laukien
Chairman33.8yrsUS$5.86m26.59%
$ 2.4b
John Ornell
Independent Director9.3yrsUS$241.01k0.014%
$ 1.2m
Robert Rosenthal
Independent Director9yrsUS$224.01k0.019%
$ 1.7m
Richard Packer
Independent Director17.5yrsUS$227.32k0.047%
$ 4.3m
William Linton
Independent Lead Director24.8yrsUS$231.01k0.022%
$ 2.0m
Adelene Perkins
Independent Director7.5yrsUS$224.01k0.013%
$ 1.1m
Hermann Requardt
Independent Director9.3yrsUS$219.01k0.014%
$ 1.2m
Bonnie Anderson
Independent Director4.2yrsUS$219.65k0.0050%
$ 453.3k
Cynthia Friend
Independent Director8.5yrsUS$216.83k0.0076%
$ 686.7k

9.3yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BRKR wordt beschouwd als ervaren (gemiddelde ambtstermijn 9.3 jaar).